Intellectual Property Law Blog
AUGUST 30, 2021
In recent years, AI patent activity has exponentially increased. The figure below shows the volume of public AI patent applications categorized by AI component in the U.S. AI patent activities by year. Inventors and patent attorneys often face the challenge of effectively protecting new AI technology development.
SpicyIP
NOVEMBER 9, 2024
In his recent work published in the Journal of Intellectual Property Law and Practice , Dr. Mo Abolkheir argues that the prevailing interpretation of ‘inventive steps’ places emphasis on the inventor’s imaginative capacity rather than the invention itself. It confuses ‘invention’ with ‘person.’
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Erik K Pelton
FEBRUARY 4, 2025
The following is an edited transcript of my video Patent, Trademark, and Copyright Definitions and Differences. The following is an edited transcript of my video Patent, Trademark, and Copyright Definitions and Differences. A patent registration generally lasts for 20 years from the time the application was filed.
SpicyIP
FEBRUARY 21, 2025
The office of CGPDTM has invited comments on the Draft Guidelines for Processing Patent Applications of Ayush Systems and Related Inventions for providing clarity on the filing and processing of patent applications of Ayush systems and related inventions. The guidelines are available on the IPIndia website here.
The IPKat
MARCH 26, 2025
The EPO Board of Appeal decision in T 0687/22 confirms beyond doubt the relevance of G 2/21 to software inventions. The decision in T 0687/22 links the case law from G 1/19 and G 2/21 to highlight t he importance of establishing a credible technical effect of software invention. Headnote II).
SpicyIP
OCTOBER 29, 2024
Malladi Drugs, SpicyIP Intern Bhuwan Sarine analyses the Court’s finding on the burden of proof in patent matters concerning revocation petitions. 64 of the Patents Act, 1970 (“the Act”). Accordingly, the Court decided in favour of Malladi Drugs (“Respondent”), upholding the validity of its patent. Petitioner”) under s.
Selvam & Selvam Blog
APRIL 1, 2025
Robert Bosch Limited, filed an appeal before the Madras High Court, challenging the rejection of their Indian Patent Application No. The FER also cited Section 3(d), excluding claims 1 to 6 from patentability. Counsel for the appellant argued that the Controller erred in applying Section 3(m) to the claimed invention.
Expert insights. Personalized for you.
242 
Let's personalize your content